Expression of hypoxic-inducible factor 1α predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 2, 2004, Pages 513-521

  Ishikawa, Hitoshi ^a,c   Sakurai, Hideyuki ^a   Hasegawa, Masatoshi ^a   Mitsuhashi, Norio ^b   Takahashi, Mitsuhiro ^a   Masuda, Norihiro ^a   Nakajima, Masanobu ^a   Kitamoto, Yoshizumi ^a   Saitoh, Jun Ichi ^a   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Cervical carcinoma; HIF 1 ; Hypoxia; Radiotherapy; Recurrence

Indexed keywords

CELLS; DISEASES; HISTOLOGY; IMMUNOLOGY; PATIENT MONITORING; TUMORS;

BRACHYTHERAPY; EXTERNAL BEAM IRRADIATION; METASTASIS; RADIOSENSITIVITY;

RADIOTHERAPY;

HYPOXIA INDUCIBLE FACTOR 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VIRUS INFECTION;

AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; PAPILLOMAVIRIDAE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 4544276339     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.03.025     Document Type: Article

References (51)

1. Hall E.J. Radiobiology for the radiologist. 5th ed:2000;Lippincott Williams & Wilkins, New York. p. 91-111
2. Hockel M., Schlenger K., Aral B., Mitze M., et al. Association between tumor hypoxia and malignant progression in advanced cancer uterine cervix. Cancer Res. 56:1996;4509-4515
3. Sundfor K., Lyng H., Rofstad E.K. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer. 78:1998;822-827
4. Rofstad E.K. Microenvironment-induced cancer metastasis. Int J Radiat Oncol Biol Phys. 76:2000;589-605
5. Fyles A.W., Milosevic M., Wong R., et al. Oxygenation predicts radiation response and survival in patients with cervical cancer. Radiother Oncol. 47:1998;149-156
6. Gatenby R.A., Kessler H.B., Rosenblum J.S., et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship in outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 14:1988;831-838
7. Lyng H., Sundfor K., Trope C., et al. Disease control of uterine cervical cancer relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res. 6:2000;1104-1112
8. Brizel D.M., Dodge R.K., Clough R.W., et al. Oxygenation of head and neck cancer changes during radiotherapy and impact on treatment outcome. Radiother Oncol. 53:1999;113-117
9. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol. 53:1999;99-104
10. Semenza G.L., Jiang B.H., Leung S.W., et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 271:1996;32529-32537
11. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 15:1999;551-578
12. Guillemin K, Krasnow. The hypoxic response: Huffing and HIFing. Cell 1997;89:9-12
13. 2 tension. Proc Natl Acad Sci. 92:1995;5510-5514
14. 2 tension. Am J Physiol. 271:1996;C1172-1180
15. Jewell U.R., Kvietikova I., Scheid A., et al. Induction of HIF-1a in response to hypoxia is instantaneous. FASEB J. 15:2001;1312-1314
16. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 12:1992;5447-5454
17. Salceda S., Caro J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J Biol Chem. 272:1997;22642-22647
18. Huang L.E., Gu J., Schau M., et al. Regulation of hypoxia-inducible factor 1α is mediated by an oxygen-dependent domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci. 95:1998;7987-7992
19. Kallio P.J., Wilson W.J., O'Brien S., et al. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J Biol Chem. 274:1999;6519-6525
20. Haugland H.K., Vukovic V., Pintilie M., et al. Expression of hypoxia-inducible factor-1α in cervical carcinomas correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys. 53:2002;854-861
21. Vukovic V., Haugland H.K., Nicklee T., et al. Hypoxia-inducible factor 1α is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res. 61:2001;7394-7398
22. Lorincz A.T., Temple G.F., Kurman R.J., et al. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst. 79:1987;671-677
23. zur Hausen H. Viruses in human cancers. Science. 254:1991;1167-1173
24. Bosch F.X., Manos M.M., Munoz N., et al. Prevalence of human papillomavirus in cervical cancer A worldwide perspective. J Natl Cancer Inst. 87:1995;796-802
25. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 49:1989;4677-4681
26. Scheffner M., Huibregtse J.M., Vierstra R.D., et al. The HPV-16 E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:1993;495-505
27. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus type 16 and 18 E6 proteins with p53. Science. 248:1990;76-79
28. Hollstein M., Sidransky D., Vogelstein B., et al. p53 mutations in human cancers. Science. 253:1991;49-53
29. Slies E., Villalobos M., Valenzuela M.T., et al. Relationship between p53 status and radiosensitivity in human tumor cell lines. Br J Cancer. 73:1996;581-588
30. McIlwrath A.J., Vasey P.A., Ross G.M., et al. Cell cycle arrests and radiosensitivity of human tumor cell lines Dependence on wild-type p53 for radiosensitivity. Cancer Res. 54:1994;3718-3722
31. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in carcinoma of the uterus, vagina, and ovary. Vol. 1b. 1979;International Federation of Gynecology and Obstetrics, Radiumheit, Sweden
32. Mitsuhashi N., Takahashi M., Nozaki M., et al. Squamous cell carcinoma of the uterine cervix Radiation therapy for patients aged 70 years and older. Radiology. 194:1995;141-145
33. Mitsuhashi N., Takahashi M., Nozaki M., et al. Evaluation of external beam therapy and three brachytherapy fractions for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 29:1994;975-982
34. Sakurai H., Mitsuhashi N., Takahashi M., et al. Analysis of recurrence of squamous cell carcinoma of the uterine cervix after definitive radiation therapy alone Patterns of recurrence, latent periods, and prognosis. Int J Radiat Oncol Biol Phys. 50:2001;1136-1144
35. Ishikawa H., Mitsuhashi N., Sakurai H., et al. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical squamous cell carcinoma treated with radiation therapy alone. Cancer. 91:2001;80-89
36. Kaplan E., Meier P. Non-parametric estimation from incomplete observation. JAMA. 53:1958;457-481
37. Harrison L.B., Chadha M., Hill R.J., et al. Impact of tumor hypoxia and anemia on radiation therapy outcome. Oncologist. 7:2002;492-508
38. Brown J.M. The hypoxic cell A target for selective cancer therapy. Eighteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 59:1999;5863-5870
39. Rofstad E.K., Sundfor K., Lyng H., et al. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer. 83:2000;354-359
40. Shweiki D., Itin A., Soffer D., et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845
41. Birner P., Schindl M., Obermair A., et al. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 60:2000;4693-4696
42. Sheridan M.T., West C.M., Cooper R.A., et al. Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy. Br J Cancer. 82:2000;1177-1182
43. Chapman J.D., Zanzonico P., Ling C.C. On measuring hypoxia in individual tumors with radiolabeled agent. J Nucl Med. 42:2001;1653-1655
44. 123I-iodoazomysin arabinoside Preliminary report of a clinical study. Br J Cancer. 65:1992;90-95
45. Saitoh J., Sakurai H., Suzuki Y., et al. Correlations between in vivo tumor weight, oxygen pressure, 31P NMR spectroscopy, hypoxic microenvironment marking by β-D-iodinated azomycin glucopyranoside (β-D-IAZGP), and radiation sensitivity. Int J Radiat Oncol Biol Phys. 54:2002;903-909
46. Carmeliet P., Dor Y., Herbert J.M., et al. Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:1998;485-490
47. Wood S.M., Wiesener M.S., Yeates K.M., et al. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 alpha-subunit (HIF-1 alpha) Characterization of hif-1 alpha-dependent and -independent hypoxia-inducible gene expression. J Biol Chem. 273:1998;8360-8368
48. Wenger R.H. Mammalian oxygen sensing, signaling, and gene regulation. J Exp Biol. 203:2000;1253-1263
49. Zhong H., De Marzo A.M., Laughner E., et al. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastasis. Cancer Res. 59:1999;5830-5835
50. Hui E.P., Chan A.T., Pezzella F., et al. Coexpression of hypoxia-inducible factors 1α and 2α, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res. 8:2002;2595-2604
51. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys. 53:2002;1192-1202